Imricor Medical Systems, Inc. is pleased to announce that it has signed a Master Purchasing Agreement with Sana Einkauf & Logistik GmbH of Ismaning Germany (Sana). Sana is the largest Group Purchasing Organisation (GPO) in Germany, with 600 cooperating hospitals and medical institutions across Germany and Switzerland. Approximately 80 of these sites perform cardiac ablations and are therefore potential Imricor customers.
Imricor Announces Completion of Enrollment for Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablations
Imricor Medical Systems announced today the completion of enrollment for the clinical study to evaluate Imricor’s Vision-MR™ Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The single-center study enrolled 35 patients and was sponsored by the University of Leipzig Heart Center in Leipzig, Germany. Professor Gerhard Hindricks MD, Head of the Department of Electrophysiology at the Leipzig Heart Center, was the principal investigator.
Imricor Awarded NIH Contract to Develop MR Compatible Catheter for MRI-Guided Cardiac Procedures
Imricor Medical Systems announced that it has been awarded a contract for up to $2.4 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop an MR compatible injection catheter for MRI-guided procedures. This ten month contract which has a two-year option period will support the continued advancement of real-time MRI guided interventions for the treatment of cardiac arrhythmias.
Imricor & MiRTLE Medical Announce Joint Development Agreement to Deliver 12 Lead ECG for MR-guided Cardiac Ablations
Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MRTM EP Recorder/Stimulator System. This integration, along with Imricor’s MR compatible catheters, will allow physicians to perform complex cardiac ablations, such as for treating ventricular tachycardia and atrial fibrillation, under real-time MRI-guidance.
Imricor and Siemens Healthineers Announce Strategic Relationship to Improve Cardiac Ablations
Siemens Healthineers is joining forces with U.S.-based Imricor Medical Systems Inc. to develop an integrated solution that combines the clinical benefits of real-time MRI scans with 3D-guided cardiac ablation. The companies’ shared goal is the development of MRI-compatible devices that translate information on cardiac conduction, morphological substrates, and individual patient anatomy into better treatment outcomes. This approach will potentially enable electrophysiologists to treat heart arrhythmia without radiation and to use the visualization of soft tissue information obtained through MRI.
Imricor Announces Enrollment of First Patients in Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablation Procedures
Imricor Medical Systems announced today the enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The study is sponsored by the Leipzig Heart Center in Leipzig, Germany. Professor Gerhard Hindricks MD, Head of the Department of Electrophysiology at the heart center, is the principal investigator. This single-center study will enroll up to 35 patients.
Imricor Receives CE Mark for MR Compatible Advantage-MR EP Recorder and Stimulator System
Imricor Medical Systems announced today that it has received CE mark for its Advantage-MR™ EP Recorder/Stimulator System; a first-of-its-kind MR Conditional recording system for MRI-guided electrophysiology (EP) procedures. The Advantage-MR system, along with Imricor’s Vision-MR™ Ablation Catheter, allows physicians to perform cardiac ablations under real-time MRI guidance with the potential to improve outcomes and provide safer, more cost-effective treatment – all in an environment that is free of radiation for both the patient and physician.
Dedicated Interventional MRI EP Lab Opens in Leipzig, Germany
Imricor Medical Systems announced the dedication of Europe’s latest interventional MRI suite for electrophysiology (EP) procedures in Leipzig, Germany. With this state-of-the-art lab, Prof. Gerhard Hindricks MD, PhD and his team of physicians at the Heart Center in Leipzig will be able to perform cardiac ablations under real-time MRI guidance using Imricor’s unique MR compatible catheters and EP devices.
Excitement Builds for Imricor’s MR-Enabled Technology at HRS 2015
At the 2015 Heart Rhythm Society Scientific Sessions in Boston, MA, attendees gathered to learn how Imricor is making MRI-guided cardiac ablations a clinical reality. Physicians from around the world visited the Imricor booth to learn more about bringing Imricor’s innovative technology to their patients and institutions. Christopher Piorkowski MD, PhD (Head of the Department of Electrophysiology, University of Dresden Heart Center) spoke to a crowd of physicians and industry experts at the Imricor booth on Thursday, May 14 about his clinical experience with MRI-guided ablations and the future of interventional MRI EP procedures. Regarding MRI-guided ablations, Piorkowski said, “All of this has beautifully matured over the years. We have been able to bring this forward into actual human clinical medicine.”
Imricor Selected as Finalist for the Twin Cities AHA Innovation Grant Challenge
The American Heart Association Advancing Sciences Breakfast selected Imricor Medical Systems as a finalist for its Twin Cities Innovation Grant Challenge; a competition for Minnesota-based med-tech companies with technology related to preventing or managing heart disease and stroke. The AHA Advancing Sciences Breakfast fosters dialogue and discovery among local business, med-tech, and life science leaders who can affect change in the fight against heart disease.